Philip D. Worboys, SVP, Research & Transl Science at Theravance Biopharma, Inc. (TBPH), sold 4,246 shares at $18.00 ($76K) on 2020-12-03, disclosed to the SEC on 2020-12-07.
Open-market sale of $76k TBPH by SVP, Research & Transl Science. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TBPH | SELL | 2018-09-14 | $364K | — | Filing → |